• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-144通过靶向Nrf2依赖性抗氧化途径逆转肝癌细胞系的化疗耐药性。

miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.

作者信息

Zhou Suna, Ye Wenguang, Zhang Yanjun, Yu Dequan, Shao Qiuju, Liang Jun, Zhang Mingxin

机构信息

Department of Radiotherapy, Tangdu Hospital, Fourth Military Medical University Xi'an, Shaanxi, China.

Department of Gastroenterology, Tangdu Hospital, Fourth Military Medical University Xi'an, Shaanxi, China.

出版信息

Am J Transl Res. 2016 Jul 15;8(7):2992-3002. eCollection 2016.

PMID:27508019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4969435/
Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Chemoresistance occurrence is a major cause of treatment failure in HCC. Currently, extensive research has revealed diverse mechanisms for chemoresistance, but the molecular mechanisms underlying the role of miRNAs in resistance to 5-FU are not confirmed in HCC cells. By quantitative real-time polymerase chain reaction (qRT-PCR) analysis, we found that miR-144 was significantly decreased in HCC cell lines. It has been further demonstrated that miR-144 were significantly down-regulated in Bel-7402/5-FU cells compared with parental Bel-7402 cells by qRT-PCR and western blot. The expression of Nrf2 was reversely correlated to that of miR-144 in HCC cells. Moreover, Enhancement of 5-FU-induced cytotoxicity and apoptosis are resulted from the transfection with miR-144 mimics in Bel-7402/5-FU cells. Mechanically, miR-144 promoted nuclear factor erythroid-2-related factor-2 (Nrf2) mRNA degradation by directly targeting the Nrf2 3'untranslated region (3'UTR). In addition, ectopic expression of miR-144 in Bel-7402/5-FU cells reduced the levels of Nrf2 and inhibited the transcription of Nrf2-dependent HO-1 gene, thus contributing to 5-FU sensibilization. Conversely, re-expression of Nrf2 partly attenuated the chemosensibilization of miR-144. Our study showed that miR-144 serves as a potential chemoresistance-reversal agent in hepatocellular carcinoma cells, which is at least partly due to the down-regulation of Nrf2-dependent antioxidant pathway.

摘要

肝细胞癌(HCC)是全球最常见的恶性肿瘤之一。化疗耐药的发生是HCC治疗失败的主要原因。目前,广泛的研究已经揭示了多种化疗耐药机制,但miRNA在5-氟尿嘧啶(5-FU)耐药中作用的分子机制在HCC细胞中尚未得到证实。通过定量实时聚合酶链反应(qRT-PCR)分析,我们发现miR-144在HCC细胞系中显著降低。通过qRT-PCR和蛋白质印迹进一步证明,与亲本Bel-7402细胞相比,miR-144在Bel-7402/5-FU细胞中显著下调。在HCC细胞中,Nrf2的表达与miR-144的表达呈负相关。此外,在Bel-7402/5-FU细胞中转染miR-144模拟物可增强5-FU诱导的细胞毒性和细胞凋亡。机制上,miR-144通过直接靶向Nrf2的3'非翻译区(3'UTR)促进核因子红细胞2相关因子2(Nrf2)mRNA的降解。此外,在Bel-7402/5-FU细胞中异位表达miR-144可降低Nrf2的水平并抑制Nrf2依赖性HO-1基因的转录,从而促进5-FU增敏。相反,重新表达Nrf2部分减弱了miR-144的化学增敏作用。我们的研究表明,miR-144在肝癌细胞中作为一种潜在的化疗耐药逆转剂,这至少部分是由于Nrf2依赖性抗氧化途径的下调。

相似文献

1
miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.微小RNA-144通过靶向Nrf2依赖性抗氧化途径逆转肝癌细胞系的化疗耐药性。
Am J Transl Res. 2016 Jul 15;8(7):2992-3002. eCollection 2016.
2
MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.微小RNA-141通过下调Keap1的表达激活Nrf2依赖的抗氧化途径,赋予肝癌细胞对5-氟尿嘧啶的抗性。
Cell Physiol Biochem. 2015;35(6):2333-48. doi: 10.1159/000374036. Epub 2015 Apr 15.
3
MicroRNA-205-5p regulates the chemotherapeutic resistance of hepatocellular carcinoma cells by targeting PTEN/JNK/ANXA3 pathway.微小RNA-205-5p通过靶向PTEN/JNK/ANXA3信号通路调控肝癌细胞的化疗耐药性。
Am J Transl Res. 2017 Sep 15;9(9):4300-4307. eCollection 2017.
4
miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.微小RNA-340通过靶向Nrf2依赖的抗氧化途径逆转肝癌细胞系的顺铂耐药性。
Asian Pac J Cancer Prev. 2014;15(23):10439-44. doi: 10.7314/apjcp.2014.15.23.10439.
5
lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.lncRNA KRAL 通过作为 ceRNA 对抗 miR-141 逆转肝癌细胞对 5-氟尿嘧啶的耐药性。
Cell Commun Signal. 2018 Aug 17;16(1):47. doi: 10.1186/s12964-018-0260-z.
6
MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.微小RNA-27a通过抑制肝癌细胞中的FZD7/β-连环蛋白通路来调节多药耐药蛋白1/ P-糖蛋白的表达。
Cell Signal. 2013 Dec;25(12):2693-701. doi: 10.1016/j.cellsig.2013.08.032. Epub 2013 Sep 7.
7
Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway.白杨素通过抑制 PI3K/Akt/Nrf2 和 ERK/Nrf2 通路增强 BEL-7402/ADM 细胞对阿霉素的敏感性。
Chem Biol Interact. 2013 Oct 25;206(1):100-8. doi: 10.1016/j.cbi.2013.08.008. Epub 2013 Aug 27.
8
MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.微小RNA-183通过微小RNA-183-异柠檬酸脱氢酶2/细胞因子信号转导抑制因子6-缺氧诱导因子-1α反馈环调节肝癌(HCC)细胞中的多药耐药性。
Eur Rev Med Pharmacol Sci. 2016 May;20(10):2020-7.
9
miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.miRNA-195 通过靶向 BCL-w 使肝癌细胞对 5-FU 敏感。
Oncol Rep. 2012 Jan;27(1):250-7. doi: 10.3892/or.2011.1472. Epub 2011 Sep 22.
10
MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.微小RNA-195通过靶向大肿瘤抑制因子2调控人肝癌细胞的细胞凋亡。
Pharmazie. 2012 Jul;67(7):645-51.

引用本文的文献

1
USP37 as a novel regulator of NRF2 protein stability and chemoresistance in HCC.USP37作为肝癌中NRF2蛋白稳定性和化疗耐药性的新型调节因子。
Discov Oncol. 2025 Mar 13;16(1):312. doi: 10.1007/s12672-025-01913-9.
2
Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC.乳酸化驱动的IGF2BP3介导的丝氨酸代谢重编程和RNA m6A修饰促进肝癌对乐伐替尼的耐药性
Adv Sci (Weinh). 2024 Dec;11(46):e2401399. doi: 10.1002/advs.202401399. Epub 2024 Oct 25.
3
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges.Nrf2 信号通路在肝细胞癌中的双重作用:促进发展、免疫逃逸和治疗挑战。
Front Immunol. 2024 Sep 2;15:1429836. doi: 10.3389/fimmu.2024.1429836. eCollection 2024.
4
DNA damage response-related ncRNAs as regulators of therapy resistance in cancer.作为癌症治疗耐药性调节因子的DNA损伤反应相关非编码RNA
Front Pharmacol. 2024 Aug 26;15:1390300. doi: 10.3389/fphar.2024.1390300. eCollection 2024.
5
The Cancer Antioxidant Regulation System in Therapeutic Resistance.治疗抗性中的癌症抗氧化调节系统
Antioxidants (Basel). 2024 Jun 27;13(7):778. doi: 10.3390/antiox13070778.
6
The interplay between microRNAs and Nrf2 signaling in human cancers.人类癌症中微小RNA与Nrf2信号通路之间的相互作用。
Cancer Cell Int. 2024 Jul 5;24(1):234. doi: 10.1186/s12935-024-03430-1.
7
microRNA-144/451 decreases dendritic cell bioactivity targeting interferon-regulatory factor 5 to limit DSS-induced colitis.microRNA-144/451 通过靶向干扰素调节因子 5 降低树突状细胞的生物活性,从而限制 DSS 诱导的结肠炎。
Front Immunol. 2022 Jul 29;13:928593. doi: 10.3389/fimmu.2022.928593. eCollection 2022.
8
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.CRISPR/Cas9 基因编辑:克服癌症耐药性的新方法。
Cell Mol Biol Lett. 2022 Jun 17;27(1):49. doi: 10.1186/s11658-022-00348-2.
9
miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.miR-144 通过 NUDCD1 抑制 IGF1R-ERK1/2 信号通路抑制结直肠癌细胞的增殖和转移:基于生物信息学和体外及体内验证的研究。
J Cancer Res Clin Oncol. 2022 Aug;148(8):1903-1918. doi: 10.1007/s00432-022-03951-0. Epub 2022 Apr 27.
10
Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters.非编码 RNA 在铁死亡癌细胞死亡通路中的作用:新的 masters 登场。
Hum Cell. 2022 Jul;35(4):972-994. doi: 10.1007/s13577-022-00699-0. Epub 2022 Apr 12.

本文引用的文献

1
MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer.微小RNA-197通过胸苷酸合成酶影响结直肠癌对5-氟尿嘧啶的耐药性。
Clin Transl Oncol. 2015 Nov;17(11):876-83. doi: 10.1007/s12094-015-1318-7. Epub 2015 Jun 9.
2
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.微小RNA-21可预测局部晚期直肠癌对术前放化疗的反应。
Int J Colorectal Dis. 2015 Jul;30(7):899-906. doi: 10.1007/s00384-015-2231-9. Epub 2015 May 8.
3
let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.let-7b和let-7c是肾细胞癌内在化学抗性的决定因素。
World J Surg Oncol. 2015 May 8;13:175. doi: 10.1186/s12957-015-0596-4.
4
Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1.微小RNA-23a表达升高通过直接靶向ABCF1增强微卫星不稳定的结肠癌细胞对5-氟尿嘧啶的化疗耐药性。
Curr Protein Pept Sci. 2015;16(4):301-9. doi: 10.2174/138920371604150429153309.
5
Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.肿瘤抑制因子miR-145通过直接靶向结直肠癌中与DNA损伤相关的基因RAD18来逆转耐药性。
Tumour Biol. 2015 Jul;36(7):5011-9. doi: 10.1007/s13277-015-3152-5. Epub 2015 Apr 27.
6
MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.微小RNA-141通过下调Keap1的表达激活Nrf2依赖的抗氧化途径,赋予肝癌细胞对5-氟尿嘧啶的抗性。
Cell Physiol Biochem. 2015;35(6):2333-48. doi: 10.1159/000374036. Epub 2015 Apr 15.
7
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
8
Indirect modulation of sensitivity to 5-fluorouracil by microRNA-96 in human colorectal cancer cells.微小RNA-96对人结肠癌细胞中5-氟尿嘧啶敏感性的间接调控
Arch Pharm Res. 2015 Feb;38(2):239-48. doi: 10.1007/s12272-014-0528-9. Epub 2014 Dec 12.
9
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.微小RNA-203通过靶向胸苷酸合成酶增强结直肠癌对5-氟尿嘧啶的化疗敏感性。
Oncol Rep. 2015 Feb;33(2):607-14. doi: 10.3892/or.2014.3646. Epub 2014 Dec 4.
10
MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells.miR-22 通过抑制自噬和促进细胞凋亡调节结直肠癌细胞对 5-FU 的敏感性。
Cancer Lett. 2015 Jan 28;356(2 Pt B):781-90. doi: 10.1016/j.canlet.2014.10.029. Epub 2014 Oct 29.